Protein Kinase C Signaling in Adenoviral Infection - ACS Publications

Subscriber access provided by CORNELL UNIVERSITY LIBRARY

Article

Protein kinase C Signaling in Adenoviral Infection Mohammad Abu Yousuf, Ji Sun Lee, Xiaohong Zhou, Mirja Ramke, Jeong Yoon Lee, James Chodosh, and Jaya Rajaiya Biochemistry, Just Accepted Manuscript • DOI: 10.1021/acs.biochem.6b00858 • Publication Date (Web): 04 Oct 2016 Downloaded from http://pubs.acs.org on October 10, 2016

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Biochemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry PKCα in Viral Infection bi-2016-00858e Yousuf, et al., page # 1

1 2

Protein kinase C Signaling in Adenoviral Infection

3 4

Funding: This work was supported by NIH grants EY013124, EY021558, and EY014104, a

5

Senior Scientific Investigator Award grant (to JC) from Research to Prevent Blindness, Inc.,

6

New York, NY, The Falk Foundation, and the Massachusetts Lions Eye Research Fund.

7 8

Mohammad A. Yousuf, Ji Sun Lee, Xiaohong Zhou, Mirja Ramke, Jeong Yoon Lee, James

9

Chodosh*, Jaya Rajaiya*

10 11

Howe Laboratory, Mass Eye and Ear Infirmary, Department of Ophthalmology, Harvard

12

Medical School, Boston, Massachusetts 02114

13 14

Running title: PKCα in Viral Infection

15 16

*Corresponding Authors: The Massachusetts Eye and Ear Infirmary, 243 Charles Street,

17

Boston, MA 02114. Telephone: 617-573-6398; Fax: 617-573-4324; Emails:

18

[email protected]; [email protected]

19 20

ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 36 PKCα in Viral Infection bi-2016-00858e Yousuf, et al., page # 2

21

ABBREVIATIONS

22

CAR, coxsackie adenovirus receptor; DAG, diacylglycerol; IP3, 1,4,5-triphosphate; MOI,

23

multiplicity of infection; PI3K, phosphoinositide 3-kinase; PKC, protein kinase C; RGD,

24

arginine-glycine-aspartate.


Page 3 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


25

ABSTRACT

26

Activation of protein kinase C (PKC), a serine/threonine protein kinase, ubiquitously influences

27

cellular signal transduction, and has been shown to play a role in viral entry. In this study, we

28

explored a role for PKC in human adenovirus type 37 infection of primary human corneal

29

fibroblasts, a major target cell for infection. We sought evidence for an interaction between PKC

30

activation and two potential downstream targets: cSrc kinase, shown previously to play a critical

31

role in adenovirus signaling in these cells, and caveolin-1, reported earlier to be important to

32

entry of adenovirus type 37. Infection of fibroblasts increased PKCα phosphorylation and

33

translocation of PKCα from the cytosol to caveolin-1 containing vesicles. Virus-induced

34

phosphorylation of both cSrc and AKT was abolished in cell lysates pretreated with calphostin

35

C, a chemical inhibitor of PKC. Inhibition of PKC also reduced virus associated phosphorylation

36

of caveolin-1, while inhibition of cSrc by the chemical inhibitor PP2 reduced only caveolin-1

37

phosphorylation, but not PKCα phosphorylation, in lipid rafts. These results suggest a role for

38

PKCα upstream to both cSrc and caveolin-1. Phosphorylated PKCα was found in the same

39

endosomal fractions as phosphorylated cSrc, and PKCα was present to a greater degree in

40

caveolin-1 pull downs from virus infected than mock infected cell lysates. Calphostin C also

41

reduced early viral gene expression, indicating that PKCα activity may be required for viral

42

entry. PKCα plays a central role in adenovirus infection of corneal fibroblasts and regulation of

43

downstream molecules, including the important lipid raft component caveolin-1.

44 45 46 47


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


48

Protein kinase C (PKC) is a family of ~80 kDa phospholipid-dependent serine/threonine kinases

49

with 10 isoforms.1 All share a common structure with an N-terminal regulatory domain, C-

50

terminal catalytic domain, and a hinge region joining the two. Conventional PKC isoforms,

51

including α, βI, βII and γ, are activated by diacylglycerol (DAG) requiring calcium, while the

52

novel isoforms δ, ε, η, and θ are activated by DAG, and do not require calcium. Atypical

53

isoforms include λ and ζ that require neither DAG nor calcium for activation. Interaction with

54

endomembranes is a key aspect of conventional PKC function. Activation of phospholipase Cβ

55

induces generation of DAG and inositol 1,4,5-triphosphate (IP3), with subsequent release of

56

calcium from the endoplasmic reticulum. Together, DAG and calcium induce the movement of

57

PKC from the cytosol to endomembranes where its kinase function is released. As a major

58

upstream signaling molecule, PKC has been shown to play a critical role in the cellular entry of

59

viruses, including rhabdovirus, alphavirus, poxvirus, herpesvirus,2 influenza virus,3 and

60

respiratory syncytial virus.4 PKC isoforms play a central role in signaling events leading to

61

alterations in the cell membrane and cytoskeleton, including the formation of caveolae,5 which

62

have been implicated in the entry of filovirus,6 human enterovirus,7 echovirus,8 and human

63

immunodeficiency virus.9,

64

recently shown to infect corneal fibroblasts by use of caveolae.11

10

Human adenovirus type 37, an important cause of keratitis, was

65

Human adenoviruses utilize at least two distinct sets of cell surface receptors for

66

attachment and internalization into target host cells. An initial interaction between the adenovirus

67

capsid fiber knob with a cellular receptor including the coxsackie adenovirus receptor (CAR),12

68

GD1a glycan,13 major histocompatibility class I,14 desmoglein,15 and CD46

69

secondary interaction between arginine-glycine-aspartate (RGD) amino acid sequences in the

70

adenoviral penton capsomer and target cell integrins αvβ3 and αvβ5.17,


18

16

enables a

The secondary

Page 5 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


71

interaction induces activation of focal adhesion kinase, cSrc, and phosphoinositide 3-kinase

72

(PI3K) that mediate endocytosis of the virus.19, 20 The same kinases act as key signaling nodes to

73

prolong cell survival, thus enabling viral replication,21 and induce expression of cytokines by

74

infected cells.22-27 In particular, cSrc is the kinase identified most upstream in the pathway

75

initiated by adenovirus infection of corneal cells.

76

Multiple lines of evidence point to functional interactions between PKC and cSrc,28-35

77

and we sought to explore the possibility of upstream control of cSrc activation by PKC in the

78

earliest stages of infection by adenovirus. We demonstrate herein that adenovirus infection

79

results in activation of PKCα, which then translocates to caveolin-1 containing vesicles, also

80

containing cSrc. Furthermore, inhibition of PKCα activity results in reduced cSrc

81

phosphorylation and decreases adenovirus early gene expression. Our data are consistent with an

82

endosomal signalosome induced by adenovirus infection, in which PKCα and cSrc act as master

83

kinases for the control of a myriad of cellular responses to viral infection.

84 85

EXPERIMENTAL PROCEDURES

86

Antibodies and Reagents. Antibodies to total PKCα, phospho-cSrc, total AKT,

87

phospho-AKT, phospho-PKCα, total caveolin-1, and isotype controls (anti-rabbit or anti-mouse)

88

were obtained from Cell Signaling Technology (Beverly, MA) and Santa Cruz Biotechnology

89

(Delaware, CA). Antibodies to total cSrc and phospho-caveolin-1 were purchased from EMD

90

Millipore (Billerica, MA) and BD Bioscience (San Jose, CA). Antibody to actin was obtained

91

from Thermo Scientific (Cambridge, MA). Inhibitors to PKC (calphostin C) and cSrc (PP2) were

92

purchased from Calbiochem (La Jolla, CA). Horseradish peroxidase-conjugated goat anti-rabbit

93

and goat anti-mouse IgG were obtained from Santa Cruz Biotechnology. Lipofectamine


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


94

RNAiMAX and OptiMEM cell culture medium were obtained from Invitrogen Life

95

Technologies (Carlsbad, CA).

96

Cell Culture and Viruses. Primary corneal fibroblasts were grown from human donor

97

corneas as previously described.36 Cells from multiple donors were pooled and the cell

98

monolayers used at passage two. The protocol for use of corneas from deceased human donors

99

was approved by the Massachusetts Eye and Ear Infirmary Human Studies Committee, and is

100

consistent with the principles expressed in the Declaration of Helsinki. In some experiments, cell

101

cultures were pretreated with the PKC inhibitor calphostin C (1 µM), the cSrc inhibitor PP2 (10

102

µM), or DMSO (control), for 3 hr prior to infection. Human adenovirus type 37 strain GW was

103

obtained from American Type Culture Collection (ATCC, Manassas, VA), was grown in A549

104

cells (CCL-185, ATCC), a human alveolar epithelial cell line, in Minimum Essential Media

105

(MEM) with 2% FBS, penicillin G sodium, streptomycin sulfate, and amphotericin B. Virus was

106

purified by cesium chloride gradient prior to use. In some instances, virus was conjugated to Cy3

107

dye (GE Healthcare, Piscataway, NJ),37 to enable visualization of viral capsid for confocal

108

microscopy, as previously described.38 One mg of Cy3 dye was reconstituted in 1 mL of 0.1 M

109

sodium bicarbonate (pH 9.3), and conjugated to virus at a concentration approximately equal to

110

1012 Ad particles/mL; reconstituted Cy3 dye was 20% of the final solution. The mixture was

111

incubated for 30 min in the dark with gentle mixing, followed by dialysis overnight to remove

112

the excess dye. Virus labeled with Cy3 grew to equal titer as unlabeled virus (data not shown).

113

Immunoblot. Adenovirus type 37 and mock infected corneal cells were lysed with cell

114

lysis buffer (Cell Signaling, Beverly, MA) containing protease inhibitor cocktail (Sigma, St.

115

Louis, MO) and incubated at 4o C for 5 min. Cell lysates were centrifuged at 13,000 × g for 10

116

min at 4o C. The protein concentration of each supernatant was measured by BCA analysis


Page 7 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


117

(Pierce, Rockford, IL) and equalized. Lysates were boiled in 1X sodium dodecyl sulfate (SDS)

118

sample buffer and separated by 4-20% Tris-glycine gel (Invitrogen) and transferred onto

119

nitrocellulose membranes (BioRad, Hercules, CA) and immunoblotted. Antibody reactivity was

120

determined with enhanced chemiluminescent reagents (Amersham Bioscience, Piscataway, NJ)

121

using horseradish peroxidase-coupled secondary antibodies. Densitometry was performed on

122

images generated on a Kodak Image Station 4000R (Rochester, NY).

123

Immunoprecipitation. Lysates obtained from adenovirus type 37 infected or mock

124

infected primary keratocytes (200 µg) were precleared with protein A-agarose beads (Thermo-

125

Fisher) for 60 min. Cleared supernatants were mixed with 3 µg of anti-caveolin-1 or isotype

126

control (anti-rabbit) and 3 µg anti-PKCα or isotype control (anti-mouse) antibodies in buffer

127

containing 50 mM Tris HCl (pH 8.5), 50 mM NaCl, 1% NP40, protease inhibitor cocktail, and

128

rocked at 4o C overnight. Then 30 µl protein A agarose was added for an additional 2 hr at 4oC.

129

Immunoprecipitates were washed three times with buffer containing 50 mM Tris HCl, 50 mM

130

NaCl, 1% NP40, protease inhibitor cocktail, and proteins were eluted by the addition of sodium

131

dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and boiled for 5

132

min. Sample were run on 4-20% Tris-glycine gel and immunoblotted.

133

Confocal Microscopy. Corneal fibroblasts were grown on slide chambers (Nunc,

134

Rochester, NY) and infected with Cy3 labeled adenovirus type 37 for the indicated times, and

135

then partially fixed in 0.05% paraformaldehyde for 10 min, washed in PBS containing 2% FBS,

136

and permeabilized in 0.1% Triton X-100 for 5 min. After 30 min blocking in 3% FBS-PBS, the

137

slides were incubated in 5 µg/ml of anti-PKCα, anti-caveolin-1, or isotype control antibodies for

138

1 hr at RT, washed three times in 1X PBS containing 2% FBS. Slides were then incubated with

139

Alexa Fluor 488 or 568 conjugated secondary antibody (Molecular Probes, Eugene, OR), washed


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


140

three times in 1X PBS containing 2% FBS, fixed in 2% paraformaldehyde, and mounted using

141

vectashield (Vector labs, Burlingame, CA) mounting medium containing DAPI. Images were

142

taken in a Leica SP5 confocal microscope using a 63x glycerol immersion objective. For

143

inhibition experiments, cells were pretreated with calphostin C (1 µM) for 3 hr and then infected

144

with Cy3 labeled adenovirus type 37 for 30 min, processed as above, and incubated in phalloidin

145

conjugated with Alexa Fluor 488 for 30 min at RT, washed and mounted. Images were taken in a

146

Leica SP5 confocal microscope using a 60x glycerol immersion objective. For quantitative

147

analysis, ImageJ was used. Three frames from 3 separate experiments were chosen in a masked

148

fashion to quantitate Cy3 labeled virus within cells.

149

Non-detergent Isolation of Lipid Rafts. Cornea fibroblasts were treated with calphostin

150

C or PP2, washed thoroughly, and infected with purified adenovirus type 37 at a multiplicity of

151

infection (MOI) of 10 (for synchronous infection) or mock infected with virus-free dialysis

152

buffer. After infection, lipid raft fractions were isolated using detergent free methods. Briefly,

153

cells were washed once in ice cold 1X PBS, suspended in 500 mM Na2CO3 and lysed by 20

154

strokes in a prechilled dounce homogenizer. Further disruption of cell membrane were achieved

155

by passing the lysates through a 23 gauge needle five times, followed by sonication for 15 sec

156

three times. The subsequent lysates were mixed with an equal volume of 90% sucrose-MBS (25

157

mM MES (2-N-morpholinoethanesulfonic acid) plus 0.15 M NaCl (pH 6.5)), overlaid on

158

equivalent volumes of 35% sucrose-MBS-Na2CO3 and 5% sucrose-MBS- Na2CO3, and

159

centrifuged for 118 hr at 4o C. 500 µl fractions were collected and the protein concentrations

160

measured and equalized. Lysates were subjected to SDS-PAGE and immunoblotted as above.

161

Endosome Isolation. Flotation gradient fractionation of post nuclear supernatants were

162

performed with 62%, (2.351 M) 35%, (1.177 M) and 25%, (0.806 M) sucrose gradients.39 One hr


Page 9 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


163

post viral infection or mock infection with dialysis buffer, cells were collected and post nuclear

164

supernatants prepared with the NucBuster Protein Extraction Kit (Novagen, San Diego, CA).

165

Post nuclear supernatants were then mixed 1:1 with 62% sucrose, layered over with 1.5 volume

166

of 35% sucrose and 1 volume of 25% sucrose and centrifuged for 1 hr at 149,000 × g at 4oC.

167

Fifty µl fractions were collected from the top of each gradient and subjected to Western blot

168

analysis and used to determine cSrc kinase activity (as below).

169

siRNA Transfection. The siRNA for PKCα was purchased from Ambion (Foster City,

170

CA). The control scRNA (On Target PlusTM control pool) was purchased from Thermo

171

Scientific. 100 picomole RNA was transfected into cells using Lipofectamine RNAiMAX

172

(Invitrogen) following the manufacturer’s instructions. At 48 hr post transfection, cells were

173

infected with adenovirus type 37 for 4 hr, and then analyzed for mRNA expression for PKCα and

174

adenovirus type 37 E1A using real-time RT-PCR. For Western blot analysis, equal amounts of

175

protein were separated in a 4-20% gradient gel (Invitrogen) and immunoblotted with antibodies

176

against PKCα and actin.

177

Polymerase Chain Reaction. For reverse transcriptase PCR, cells were infected with

178

virus at an MOI of 10. Following 1 hr incubation, cells were washed twice with PBS and

179

incubated an additional 4 hr with fresh media. Total RNA was isolated using TRIzol (Invitrogen)

180

according to the manufacturer’s protocol. RNA concentrations and quality were analyzed on a

181

Bio-Rad Smart-Spec Plus (Bio-Rad, Hercules, CA). To remove any genomic DNA

182

contamination, RNA was treated with Turbo DNase (Ambion). For synthesis of cDNA, 2 µg of

183

total RNA was reverse transcribed with Moloney murine leukemia virus reverse transcriptase

184

(Promega, Madison, WI) using an oligo(dT) 15 primer (Promega). A reaction without reverse

185

transcription was run with each experiment to rule out the possibility of amplification of


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


186

contaminating genomic DNA in the PCR step. The cDNA product was amplified by PCR in a

187

total volume of 25 µl of PCR mix, including 12.5 µl of 2 × PCR master mix (Promega), 8.5 µl

188

ddH2O, and 1 µl of each primer (10 pmol). The PCR reaction was performed using the following

189

cycling parameters: 95oC for 5 min for the initial denaturation step, 30 cycles of 95oC for 30 sec,

190

54oC for 30 sec, 72oC for 30 sec, followed by the final extension at 72oC for 10 min and then

191

kept at 4oC until analysis. The amplification products were analyzed by gel electrophoresis on

192

1% agarose gel. PCR products were visualized after ethidium bromide staining using a Kodak

193

Image Station 4000R.The primers used for PCR amplification in reverse transcriptase PCR were

194

as

195

5'ATCATCCCTGCCTCTACTGG3';

196

adenovirus

197

5'GCTGGGACCTACACTTCAGG3'; reverse: 5'TGTAACACAGAGCGCAGGAG3'.

follows:

for

type

GAPDH

37

E1A

(GenBank

13S

reverse:

Acc.

no.

NM

002046.3)

forward:

5'GTCAGGTCCACCACTGACAC3';

(GenBank

Acc.

no.

DQ900900)

for

forward:

198

For real-time quantitative PCR, total RNA was extracted from treated cells using TRIzol

199

(Invitrogen) according to the manufacturer’s instructions. Total RNA was then treated with

200

DNase I (1 unit) (New England BioLabs, Ipswich, MA) at 37° C for 1 hr. Two µg of the DNase

201

treated RNA was subjected to reverse transcription with M-MLV reverse transcriptase

202

(Promega) and oligo dT15 primers (IDT). Primers for PKCα, caveolin-1 and E1A were designed

203

using Primer3 plus software (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi),

204

and synthesized by IDT (Table 1). cDNAs were diluted 1:10 and 1 µl used for qRT-PCR with

205

Fast SYBR Green master mix (Thermo Fisher) under the conditions: 40 cycles at 95° C (30 sec),

206

60° C (1 min), 72° C (30 sec), and a final extension at 72° C (10 min). A non-template control

207

and endogenous control (human GAPDH) were measured for relative quantification. The relative


Page 11 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


208

expression levels were calculated by the 2-∆∆CT method against untransfected/uninfected

209

controls.40

210

Src Kinase Assay. Src activity in endosomal fractions was assessed by the ProFluor®

211

Src-Family Kinase Assay (Promega). Two µg of pooled endosomal fractions # 7-10 (peptide

212

substrate) and 25 µl of 100 µM ATP was added to the reaction buffer and incubated for 60 min

213

at room temperature, followed by the addition of protease reagent for another 60 min at RT. The

214

reaction was then stopped by addition of stabilizer reagent. In the presence of active kinase, the

215

peptide substrate is phosphorylated, effectively blocking the protease activity and resulting in

216

low fluorescence of the substrate. When there is no kinase activity, the peptide substrate remains

217

unphosphorylated, and the protease will remove all amino acids from the peptide substrate and

218

liberate the highly fluorescent rhodamine 110. Therefore, kinase activity is inversely

219

proportional to fluorescence. The resulting fluorescence was read with at excitation wavelength

220

485 and emission wavelength of 530 nm.

221

Statistical analysis. The results of at least 3 independent experiments were first checked

222

for normality, and then subjected to analysis by ANOVA with α = .05. All analysis was

223

performed in SAS (Cary, NC).

224 225

RESULTS

226

PKCα activation and translocation in adenovirus infection. As a first step toward the

227

study of PKC in adenovirus infection of corneal cells, we subjected serum starved, primary,

228

human corneal fibroblasts in culture to Western blot analysis for one PKC isoform of each

229

activation group (conventional, novel, and atypical) (Figure 1A). PKCα was identified in

230

fibroblasts at the expected 80 kDa molecular weight by use of an isoform specific antibody,


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


231

while bands for PKCθ and PKCζ were not seen. To determine whether PKCα was activated by

232

infection with adenovirus, we infected the cells with 10 viral infectious units per cell

233

(multiplicity of infection, MOI = 10) for one hr, or mock infected with virus-free dialysis buffer,

234

and immunoblotted with antibody against phosphorylated PKCα. Other cells were pretreated

235

with the PKC inhibitor, calphostin C

236

increased phosphorylation of PKCα relative to total PKCα, and this effect was diminished by

237

calphostin C pretreatment (Figure 1B). Densitometry analysis performed on three consecutive

238

Western blots showed a significant increase in PKCα phosphorylation, and confirmed the effect

239

of calphostin C on PKCα phosphorylation in adenovirus infection (Figure 1C; p

Protein Kinase C Signaling in Adenoviral Infection - ACS Publications

Recommend Documents